New oral anti-coagulants versus vitamin K antagonists in high thromboembolic risk patients

BACKGROUND: Oral anticoagulant therapy (VKA) is nowadays the mainstay of treatment in primary and secondary stroke prevention in patients with atrial fibrillation. Given the limited risk-benefit ratio of vitamin K antagonists, pharmacological research has been directed towards the development of pro...

Descripción completa

Detalles Bibliográficos
Autores principales: Bellin, Annachiara, Berto, Patrizia, Themistoclakis, Sakis, Chandak, Aastha, Giusti, Pietro, Cavalli, Giacomo, Bakshi, Sumeet, Tessarin, Michele, Deambrosis, Paola, Chinellato, Alessandro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6779249/
https://www.ncbi.nlm.nih.gov/pubmed/31589620
http://dx.doi.org/10.1371/journal.pone.0222762

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6779249/
https://www.ncbi.nlm.nih.gov/pubmed/31589620
http://dx.doi.org/10.1371/journal.pone.0222762

Ejemplares similares